The main pharmacological effect of anti-heart failure drugs is to address heart failure caused by reduced or impaired myocardial contractile function.
| NO. | PubChem ID | CAS Number | Molecular Name | Efficacy | Efficacy_Chinese |
|---|---|---|---|---|---|
| 41 | 13257 | 0 | 1-methylphenanthrene | anti-heart failure | 抗心力衰竭 |
| 42 | 15506 | 1678-93-9 | butylcyclohexane | anti-heart failure | 抗心力衰竭 |
| 43 | 15512 | 1679-51-2 | cyclohex-3-en-1-ylmethanol | anti-heart failure | 抗心力衰竭 |
| 44 | 68229 | 523-59-1 | 8,8-dimethylpyrano[2,3-f]chromen-2-one | anti-heart failure | 抗心力衰竭 |
| 45 | 68316 | 539-52-6 | 3-(4-methylpent-3-enyl)furan | anti-heart failure | 抗心力衰竭 |
| 46 | 72276 | 17334-50-8 | (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | anti-heart failure | 抗心力衰竭 |
| 47 | 72300 | 528-43-8 | 2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol | anti-heart failure | 抗心力衰竭 |
| 48 | 72303 | 35354-74-6 | 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol | anti-heart failure | 抗心力衰竭 |
| 49 | 73111 | 0 | (9R)-9-[(9R)-2-carboxy-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid | anti-heart failure | 抗心力衰竭 |
| 50 | 79518 | 5445-31-8 | 2-methylnonan-3-one | anti-heart failure | 抗心力衰竭 |